DXCM

DEXCOM INC

US StockNASDAQSurgical & Medical Instruments & Apparatus

Research the business. Follow the filings.

Financial information from SEC disclosures, with reporting periods kept in context.

Revenue

4.7B USDAnnual · FY 2025

Operating income

911.8M USDAnnual · FY 2025

Net income

836.3M USDAnnual · FY 2025

Total assets

6.3B USDAnnual · FY 2025

Equity

2.7B USDAnnual · FY 2025

Operating cash flow

1.4B USDAnnual · FY 2025

DXCM · Chart

Chart provided by TradingView. Loading the chart connects your browser to TradingView and sends necessary technical information such as your IP address, page URL, and displayed symbol.

Reported financial information

Revenue

USD

4.7B USD

Period data
PeriodValue
FY 20212.4B USD
FY 20222.9B USD
FY 20233.6B USD
FY 20244B USD
FY 20254.7B USD

Operating income

USD

911.8M USD

Period data
PeriodValue
FY 2021265.8M USD
FY 2022391.2M USD
FY 2023597.7M USD
FY 2024600M USD
FY 2025911.8M USD

Net income

USD

836.3M USD

Period data
PeriodValue
FY 2021216.9M USD
FY 2022341.2M USD
FY 2023541.5M USD
FY 2024576.2M USD
FY 2025836.3M USD

Total assets

USD

6.3B USD

Period data
PeriodValue
FY 20214.9B USD
FY 20225.4B USD
FY 20236.3B USD
FY 20246.5B USD
FY 20256.3B USD

Equity

USD

2.7B USD

Period data
PeriodValue
FY 20212B USD
FY 20222.1B USD
FY 20232.1B USD
FY 20242.1B USD
FY 20252.7B USD

Operating cash flow

USD

1.4B USD

Period data
PeriodValue
FY 2021442.5M USD
FY 2022669.5M USD
FY 2023748.5M USD
FY 2024989.5M USD
FY 20251.4B USD

Revenue growth

%

15.6%

Period data
PeriodValue
FY 202127.1%
FY 202218.8%
FY 202324.5%
FY 202411.3%
FY 202515.6%

Operating income growth

%

52%

Period data
PeriodValue
FY 2021-11.3%
FY 202247.2%
FY 202352.8%
FY 20240.4%
FY 202552%

Net income growth

%

45.1%

Period data
PeriodValue
FY 2021-60.5%
FY 202257.3%
FY 202358.7%
FY 20246.4%
FY 202545.1%

Operating margin

%

19.6%

Period data
PeriodValue
FY 202110.9%
FY 202213.4%
FY 202316.5%
FY 202414.9%
FY 202519.6%

Net margin

%

17.9%

Period data
PeriodValue
FY 20218.9%
FY 202211.7%
FY 202314.9%
FY 202414.3%
FY 202517.9%

Return on assets

%

13%

Period data
PeriodValue
FY 20214.7%
FY 20226.6%
FY 20239.3%
FY 20249%
FY 202513%

Debt/Equity

x

1.31x

Period data
PeriodValue
FY 20211.42x
FY 20221.53x
FY 20232.03x
FY 20242.08x
FY 20251.31x